3001

COM:ZHIFEISHENGWU

重庆智飞生物制品股份有限公司

  • Stock

Last Close

29.77

22/11 07:04

Market Cap

65.07B

Beta: -

Volume Today

29.52M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
193.72M
-
157.32M
18.79%
130.27M
17.19%
106.20M
18.48%
366.05M
244.68%
1.21B
229.46%
2.13B
76.98%
2.95B
37.98%
5.40B
83.21%
7.70B
42.77%
8.50B
10.39%
average payables
88.79M
-
98.24M
10.64%
82.49M
16.03%
64.31M
22.04%
372.32M
478.96%
1.17B
214.59%
1.94B
65.43%
2.65B
36.95%
6.13B
131.07%
9.49B
54.82%
11.47B
20.88%
average receivables
438.16M
-
439.15M
0.23%
440.52M
0.31%
406.47M
7.73%
576.22M
41.76%
1.42B
146.68%
3.30B
131.95%
5.61B
70.16%
9.87B
76.01%
16.89B
71.07%
23.90B
41.46%
book value per share
0.95
-
1.02
7.58%
0.97
4.85%
1.01
3.30%
1.19
18.42%
1.70
42.31%
2.33
37.46%
3.35
43.52%
7.17
114.06%
15.15
111.38%
13.13
13.34%
capex per share
-0.08
-
-0.12
43.84%
-0.09
22.82%
-0.12
38.07%
-0.09
23.84%
-0.19
107.83%
-0.23
19.40%
-0.34
44.34%
-0.78
133.64%
-0.91
15.82%
-0.47
47.97%
capex to depreciation
-8.04
-
-8.56
6.50%
-5.54
35.30%
-5.68
2.59%
-3.80
33.08%
-5.65
48.53%
-6.47
14.58%
-6.84
5.65%
-5.14
24.83%
-4.61
10.25%
-3.35
27.36%
capex to operating cash flow
-0.91
-
-1.72
88.83%
-1.01
41.14%
-3.42
239.01%
-1.13
66.89%
-0.82
27.73%
-0.42
48.85%
-0.24
43.57%
-0.23
3.97%
-0.73
221.68%
-0.13
82.74%
capex to revenue
-0.26
-
-0.35
33.97%
-0.32
8.42%
-0.69
118.12%
-0.17
75.11%
-0.09
46.63%
-0.05
41.03%
-0.05
0.60%
-0.06
15.78%
-0.04
39.75%
-0.02
43.31%
cash per share
0.48
-
0.42
12.62%
0.32
24.16%
0.26
18.59%
0.35
35.63%
0.30
15.34%
0.46
52.50%
0.56
23.62%
1.73
206.59%
1.64
5.13%
2.64
61.21%
days of inventory on hand
192.00
-
179.20
6.67%
277.94
55.10%
1.08K
289.47%
795.29
26.53%
275.39
65.37%
147.79
46.33%
134.12
9.25%
172.56
28.66%
115.28
33.20%
84.66
26.56%
days payables outstanding
124.77
-
107.07
14.18%
190.04
77.48%
568.02
198.90%
874.07
53.88%
255.07
70.82%
132.21
48.17%
121.47
8.12%
214.45
76.54%
140.96
34.27%
123.81
12.16%
days sales outstanding
205.05
-
200.52
2.21%
225.85
12.63%
304.41
34.78%
212.20
30.29%
143.97
32.15%
156.23
8.51%
160.72
2.88%
155.52
3.24%
197.70
27.13%
187.54
5.14%
debt to assets
-0.02
-
0.02
197.80%
0.00
-
0.06
11,284.30%
0.09
44.00%
0.22
138.91%
0.19
13.30%
0.03
85.59%
0.05
96.57%
0.06
12.01%
debt to equity
-0.02
-
0.02
199.73%
0.00
-
0.09
14,706.91%
0.15
67.82%
0.41
179.25%
0.35
16.00%
0.05
86.71%
0.08
81.13%
0.10
13.89%
dividend yield
0.01
-
0.01
8.53%
0.00
47.02%
0.00
8.85%
0.00
88.34%
0.00
620.52%
0.01
336.55%
0.00
64.19%
0.00
10.18%
0.01
157.28%
0.01
44.25%
earnings yield
0.01
-
0.01
42.98%
0.01
30.80%
0.00
81.59%
0.01
428.22%
0.02
142.45%
0.03
91.40%
0.01
53.16%
0.05
267.09%
0.08
61.35%
0.06
31.89%
enterprise value
18.34B
-
14.56B
20.61%
29.11B
99.98%
26.11B
10.30%
66.75B
155.63%
93.14B
39.53%
80.70B
13.35%
238.11B
195.06%
195.87B
17.74%
90.66B
53.72%
140.09B
54.53%
enterprise value over ebitda
80.13
-
66.02
17.60%
103.46
56.70%
202.61
95.83%
107.57
46.91%
49.59
53.90%
26.75
46.07%
56.07
109.65%
15.51
72.35%
9.43
39.20%
14.68
55.70%
ev to operating cash flow
82.75
-
90.19
8.99%
130.27
44.44%
290.27
122.82%
327.82
12.94%
159.05
51.48%
59.03
62.88%
68.10
15.35%
23.02
66.19%
45.58
97.97%
15.57
65.83%
ev to sales
23.50
-
18.17
22.67%
40.84
124.73%
58.55
43.37%
49.72
15.09%
17.81
64.17%
7.62
57.21%
15.67
105.65%
6.39
59.23%
2.37
62.92%
2.66
12.24%
free cash flow per share
0.01
-
-0.05
698.03%
-0.00
98.14%
-0.09
9,633.62%
-0.01
87.31%
0.04
488.29%
0.32
650.76%
1.08
236.21%
2.67
146.30%
0.33
87.45%
3.28
878.01%
free cash flow yield
0.00
-
-0.01
820.05%
-0.00
98.98%
-0.01
10,653.42%
-0.00
95.04%
0.00
380.42%
0.01
781.33%
0.01
12.89%
0.03
192.39%
0.01
82.19%
0.05
833.48%
graham net net
0.57
-
0.48
14.59%
0.39
19.87%
0.32
18.15%
0.24
23.19%
0.22
9.09%
0.23
4.18%
0.46
100.61%
2.17
369.17%
5.26
141.87%
5.26
0.18%
graham number
1.05
-
1.19
13.03%
1.31
9.63%
0.54
58.51%
2.17
299.98%
4.74
118.58%
7.10
49.71%
10.05
41.50%
25.85
157.28%
40.07
55.05%
31.51
21.36%
income quality
1.70
-
1.09
35.85%
1.13
3.81%
2.77
144.37%
0.47
82.97%
0.40
14.34%
0.58
43.17%
1.06
83.36%
0.83
21.32%
0.26
68.34%
1.11
322.54%
intangibles to total assets
0.11
-
0.11
0.70%
0.11
2.51%
0.12
2.59%
0.08
33.39%
0.06
25.12%
0.04
25.49%
0.04
0.67%
0.03
37.65%
0.03
5.44%
0.03
5.61%
interest coverage
5.98
-
65.88
-
63.36
3.82%
36.97
41.66%
30.64
17.12%
213.73
597.65%
164.34
23.11%
113.66
30.84%
interest debt per share
-0.01
-
0.02
303.16%
0.00
-
0.11
17,958.32%
0.26
141.98%
1.00
279.61%
1.22
21.99%
0.35
70.88%
1.30
267.68%
1.29
1.23%
inventory turnover
1.90
-
2.04
7.14%
1.31
35.53%
0.34
74.32%
0.46
36.11%
1.33
188.79%
2.47
86.33%
2.72
10.19%
2.12
22.27%
3.17
49.69%
4.31
36.16%
invested capital
-0.02
-
0.02
199.73%
0.00
-
0.09
14,706.91%
0.15
67.82%
0.41
179.25%
0.35
16.00%
0.05
86.71%
0.08
81.13%
0.10
13.89%
market cap
19.55B
-
15.52B
20.58%
29.92B
92.74%
26.77B
10.53%
67.36B
151.65%
93.28B
38.48%
79.47B
14.81%
236.67B
197.83%
199.36B
15.76%
91.25B
54.23%
143.40B
57.15%
net current asset value
1.55B
-
1.36B
12.25%
1.15B
15.84%
950.01M
17.17%
1.12B
17.62%
1.99B
77.85%
2.97B
49.53%
4.57B
53.81%
12.36B
170.52%
17.65B
42.72%
24.02B
36.10%
net debt to ebitda
-5.29
-
-4.38
17.11%
-2.88
34.42%
-5.10
77.27%
-0.99
80.59%
-0.08
92.01%
0.41
617.40%
0.34
17.27%
-0.28
181.67%
-0.06
77.83%
-0.35
465.44%
net income per share
0.05
-
0.06
18.75%
0.08
26.32%
0.01
83.33%
0.18
1,251.00%
0.59
235.71%
0.96
63.05%
1.34
39.51%
4.14
209.23%
4.71
13.73%
3.36
28.64%
operating cash flow per share
0.09
-
0.07
23.82%
0.09
31.12%
0.04
59.27%
0.08
130.05%
0.24
187.57%
0.55
133.44%
1.42
155.79%
3.45
143.31%
1.24
64.00%
3.75
201.53%
payables turnover
2.93
-
3.41
16.52%
1.92
43.66%
0.64
66.54%
0.42
35.01%
1.43
242.67%
2.76
92.93%
3.00
8.84%
1.70
43.36%
2.59
52.14%
2.95
13.85%
receivables turnover
1.78
-
1.82
2.25%
1.62
11.21%
1.20
25.81%
1.72
43.46%
2.54
47.39%
2.34
7.84%
2.27
2.80%
2.35
3.35%
1.85
21.34%
1.95
5.42%
research and ddevelopement to revenue
0.04
-
0.05
14.34%
0.08
67.73%
0.13
61.55%
0.06
55.79%
0.03
53.17%
0.02
41.42%
0.02
23.18%
0.02
8.61%
0.02
23.82%
0.02
17.64%
return on tangible assets
0.06
-
0.06
8.15%
0.08
35.43%
0.01
83.64%
0.11
740.13%
0.23
98.23%
0.23
0.10%
0.23
0.30%
0.35
53.98%
0.20
41.52%
0.17
19.15%
revenue per share
0.31
-
0.33
7.37%
0.28
15.72%
0.18
36.70%
0.54
205.99%
2.12
289.38%
4.30
102.50%
6.16
43.48%
12.44
101.79%
23.92
92.24%
21.95
8.22%
roe
0.05
-
0.06
10.38%
0.08
32.76%
0.01
83.87%
0.15
1,040.88%
0.35
135.90%
0.41
18.61%
0.40
2.80%
0.58
44.46%
0.31
46.20%
0.26
17.66%
roic
0.05
-
0.06
5.81%
0.08
32.17%
0.01
86.42%
0.14
1,221.59%
0.31
122.93%
0.30
3.20%
0.30
1.31%
0.56
85.15%
0.29
48.14%
0.23
20.01%
sales general and administrative to revenue
0.05
-
0.04
22.61%
0.02
37.07%
0.06
157.77%
0.02
65.60%
0.01
65.26%
0.01
26.81%
0.00
16.06%
0.00
32.04%
0.00
18.31%
0.00
14.86%
shareholders equity per share
0.95
-
1.02
7.58%
0.97
4.85%
1.01
3.30%
1.19
18.42%
1.70
42.31%
2.33
37.46%
3.35
43.52%
7.17
114.06%
15.15
111.38%
13.13
13.34%
stock based compensation to revenue
tangible asset value
2.10B
-
2.16B
2.69%
2.16B
0.36%
2.21B
1.89%
2.62B
18.74%
3.78B
44.54%
5.27B
39.32%
7.59B
44.01%
16.85B
121.91%
23.16B
37.45%
30.39B
31.22%
tangible book value per share
0.84
-
0.90
7.40%
0.85
4.96%
0.88
3.08%
1.06
20.68%
1.54
44.52%
2.14
39.32%
3.08
44.01%
6.84
121.91%
14.48
111.67%
12.66
12.52%
working capital
1.61B
-
1.49B
7.73%
1.23B
17.12%
1.04B
15.91%
1.22B
17.22%
2.08B
71.08%
3.09B
48.71%
4.72B
52.54%
12.88B
172.91%
18.18B
41.14%
24.43B
34.34%

All numbers in (except ratios and percentages)